Quality of recovery in patients administered remimazolam versus those administered an inhalant agent for the maintenance of general anesthesia: a randomized control trial

BACKGROUND: Remimazolam is a novel intravenous benzodiazepine that is appropriate for the maintenance of anesthesia. Quality of recovery is an important component of health care quality, but there is no published randomized control trial focused on the quality of recovery in patients undergoing tota...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Seung Woo, Jang, Yo Nam, Yoon, Min-Woo, Jeon, Yeong-Gwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288018/
https://www.ncbi.nlm.nih.gov/pubmed/35842575
http://dx.doi.org/10.1186/s12871-022-01770-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288018/
https://www.ncbi.nlm.nih.gov/pubmed/35842575
http://dx.doi.org/10.1186/s12871-022-01770-x

Ejemplares similares